Antimicrobial resistance in anaerobes

Clinical Infectious Diseases

Volumn 24, Issue 1 SUPPL., 1997, Pages

  Rasmussen, B A ^a   Bush, K ^a   Tally, F P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CHLORAMPHENICOL; CLINDAMYCIN; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTEROIDES FRAGILIS; CLOSTRIDIUM PERFRINGENS; FUSOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTEROIDES; BACTEROIDES INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS;

EID: 0031021119     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.supplement_1.s110     Document Type: Article

References (15)

1. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in Bacteroides. Clin Infect Dis 1993;16(suppl 4):S390-400.
2. Chen SCA, Gottlieb T, Palmer JM, Morris G, Gilbert GL. Antimicrobial susceptibility of anaerobic bacteria in Australia. J Antimicrob Chemother 1992;30:811-20.
3. Bourgault A-M, Lamothe F, Hoban DJ, et al. Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrob Agents Chemother 1992;36:343-7.
4. Horn R, Lavallée J, Robson HG. Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents. Antimicrob Agents Chemother 1992;36:2051-3.
5. Suata K, Watanabe K, Ueno K, Homma M. Antimicrobial susceptibility patterns and resistance transferability among Bacteroides fragilis group isolates from patients with appendicitis in Bali, Indonesia. Clin Infect Dis 1993;16:561-6.
6. Betriu C, Cabronero C, Gomez M, Picazo JJ. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur J Clin Microbiol Infect Dis 1992;11:352-6.
7. Hill GB, Ayers OM, Everett BQ. Susceptibilities of anaerobic Gram-negative bacilli to thirteen antimicrobials and β-lactamase inhibitor combinations. J Antimicrob Chemother 1991;28:855-67.
8. Cuchural GJ Jr, Snydman DR, McDermott L, et al. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. Clin Ther 1992;14:122-36.
9. Aldridge KE, Gelfand M, Reller LB, et al. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamycins, penicillins, clindamycin, and metronidazole in the United States. Diagn Microbiol Infect Dis 1994;18:235-41.
10. Phillips I, King A, Nord CE, Hoffstedt B. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group. Eur J Clin Microbiol Infect Dis 1992;11:292-304.
11. Mastrantonio P, Spigaglia P, Sebastianelli A. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis. Eur J Clin Microbiol Infect Dis 1994;13:475-80.
12. Watanabe K, Ueno K, Kato N, et al. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan. Eur J Clin Microbiol Infect Dis 1992;11:1069-73.
13. Bandoh K, Ueno K, Watanabe K, Kato N. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clin Infect Dis 1993;16(suppl 4):S382-6..
14. Goldstein EJC, Citron DM, Cherubin CE, Hillier SL. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. J Antimicrob Chemother 1993;31:363-72.
15. Tunér K, Nord CE. Antibiotic susceptibility of anaerobic bacteria in Europe. Clin Infect Dis 1993;16(suppl 4):S387-9.